Publications by authors named "Maria Jesus Vidal"

Claim this Profile
G
Genetic evolution and relapse-associated mutations in adult T-cell acute lymphoblastic leukemia patients treated in PETHEMA trials.
Celia González-Gil, Thaysa Lopes, Mireia Morgades, Francisco Fuster-Tormo, Pau Montesinos, María Jesús Vidal

Hemasphere· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From Clinical Perception to Implicit Bias: Understanding Personality Traits in Lymphoma Patients.
Fátima Roso-Bas, María Dolores Alonso-Llobregat, Leyre Bento, Blanca Sánchez-González, Layla Aoukhiyad Lebrahimi, María-Jesús Vidal

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-risk HPLLs/ABC score patients with splenic marginal zone lymphoma can be safely managed without treatment: Results from a prospective Spanish study.
Ana Muntañola, María Teresa Villalobos, Sonia González-Villambrosia, María José Rodríguez-Salazar, Ana Jiménez-Ubieto, María Jesús Vidal

Br J Haematol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
Celia González-Gil, Mireia Morgades, Thaysa Lopes, Francisco Fuster-Tormo, Jesús García-Chica, María Jesús Vidal

Haematologica· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TRAF3 alterations are frequent in del-3'IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features.
Claudia Pérez-Carretero, María Hernández-Sánchez, Teresa González, Miguel Quijada-Álamo, Marta Martín-Izquierdo, María-Jesús Vidal

Am J Hematol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liquid biopsy: a non-invasive approach for Hodgkin lymphoma genotyping.
Miguel Alcoceba, María García-Álvarez, M Carmen Chillón, Cristina Jiménez, Alejandro Medina, María Jesús Vidal

Br J Haematol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes and prognostic factors of adults with refractory or relapsed T-cell acute lymphoblastic leukemia included in measurable residual disease-oriented trials.
Josep-Maria Ribera, Mireia Morgades, Eulàlia Genescà, Eduardo-Cerello Chapchap, Pau Montesinos, María-Jesús Vidal

Hematol Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment.
Mariana Bastos Oreiro, Reyes Martín, Pilar Gomez, Nieves López Muñoz, Antonia Rodriguez, María Jesús Vidal

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications.
Claudia Pérez-Carretero, María Hernández-Sánchez, Teresa González, Miguel Quijada-Álamo, Marta Martín-Izquierdo, María-Jesús Vidal

Int J Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review on the screnning of cancer in glomerulonephritis.
Elena Monfá, Irene Padilla, Benjamin de León, Maria Jesús Vidal, Carmen Barnes

Nefrologia (Engl Ed)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient General Condition at Diagnosis: A Systematic Evaluation for Adults Diagnosed with Hematologic Malignancies.
Fernando Ramos, Paola González-Carmona, María Isabel Porras-Guerra, Sonia Jiménez-Mola, Ana María Martínez-Peláez, María Jesús Vidal

J Pers Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of a Phase II Trial of Six Cycles of Dose-Dense R-CHOP-14 for First-Line Treatment of Diffuse Large B-Cell Lymphoma in Young and Elderly Patients.
Eva González-Barca, Miguel A Canales, Antonio Salar, Secundino Ferrer, Eva Domingo-Domenech, María-Jesús Vidal

Acta Haematol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequence variants at the TERT-CLPTM1L locus associate with many cancer types.
Thorunn Rafnar, Patrick Sulem, Simon N Stacey, Frank Geller, Julius Gudmundsson, Maria Jesus Vidal

Nat Genet· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An unusual presentation of primary malignant lymphoma of the spleen.
Enrique Antón, Maria Jesus Vidal, Carmen Lobo

Am J Hematol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis